4.6 Editorial Material

Calling for rapid development of a safe and effective MERS vaccine

Journal

MICROBES AND INFECTION
Volume 16, Issue 7, Pages 529-531

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.micinf.2014.05.002

Keywords

Coronavirus; MERS-CoV; Receptor; Receptor-binding domain; Vaccine

Ask authors/readers for more resources

The geographic spread and rapid increase in the cases of Middle East respiratory syndrome (MERS) caused by a novel coronavirus (MERS-CoV) during the past two months have raised concern about its pandemic potential. Here we call for the rapid development of an effective and safe MERS vaccine to control the spread of MERS-CoV. (C) 2014 Published by Elsevier Masson SAS on behalf of Institut Pasteur.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available